Name of bioresource/bank
The Gothenburg MCI Study
Name of Principal Investigator
| Title | Professor |
| First name | Anders |
| Last name | Wallin |
Address of institution where award is held
| Institution | Neuroscience and Physiology |
| Street Address | The Memory Clinic, Sahlgrenska University Hospital |
| City | |
| Postcode | 421 41 |
Country
Sweden
Website
http://www.neurophys.gu.se/sektioner/psykiatri_och_neurokemi/kogn_stor/
Contact email (e.g. manager or coordinator)
Funding source
1) Swedish Research Council
2) LUA-ALF
Q1 What conditions does your resource cover?
Alzheimer’s disease and other dementias Neurodegenerative disease in general
Q2a What DNA collection does your resources hold?
101-1000 donors
Q2b What cell lines does your resource hold?
None
Q2c What tissue (including post-mortem tissue) does your resource hold?
101-1000 donors
Q3 Are human tissues/samples/DNA from
Living donors:blood Living donors: DNA Living donors: cerebro-spinal fluid
Q4 Are tissues/samples/DNA from
Healthy individuals/control donors Patients
Q5 Can samples be linked to clinical (phenotypic) information and if so, is this information:
Routinely collected as medical records In a specific study-associated dataset
Q6 In what form are samples supplied?
Primary Samples: Stabilised samples (frozen or fixed)
Q7 Are biomarkers/analytes/biological characteristics already measured and the information available for your samples?
In all samples
Q8 What is the status of your tissue/sample/DNA collection?
Q9 What are the rules and procedures for access?
Apply to PI or co-ordinator at resource